Page last updated: 2024-10-20

pyrazinamide and Cognition Disorders

pyrazinamide has been researched along with Cognition Disorders in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"Patients with non-communicating hydrocephalus received ventriculo-peritoneal shunts shortly after admission while communicating hydrocephalus was treated with oral acetazolamide (100 mg/kg/day) and furosemide (1 mg/kg/day) in 3-4 divided doses."1.31Long-term follow up of childhood tuberculous meningitis. ( Burger, M; Donald, P; Fertig, G; Schoeman, J; Springer, P; van Rensburg, AJ; van Zyl, F; Wait, J, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schoeman, J1
Wait, J1
Burger, M1
van Zyl, F1
Fertig, G1
van Rensburg, AJ1
Springer, P1
Donald, P1

Other Studies

1 other study available for pyrazinamide and Cognition Disorders

ArticleYear
Long-term follow up of childhood tuberculous meningitis.
    Developmental medicine and child neurology, 2002, Volume: 44, Issue:8

    Topics: Acetazolamide; Anti-Inflammatory Agents; Antitubercular Agents; Brain; Child; Cognition Disorders; D

2002